RT @SaadMahmoodMD: Great case… If Anthracycline are expected to be best option then maybe pretreat with Dexrazoxane given the LVNC? Don’t…
Great case… If Anthracycline are expected to be best option then maybe pretreat with Dexrazoxane given the LVNC? Don’t think Dexrazoxane truly limits Anthracycline efficacy or drives secondary malignancies: https://t.co/qa1jo4SHJc
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
👇👇
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
@OncoAlert
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
RT @Dr_Mike_Fradley: Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline…
Dexrazoxane reduced risk of clinical heart failure & cardiac events in pts with breast cancer undergoing anthracycline chemo with/without trastuzumab. No sig impact on cancer outcomes #cardioonc #jacccardioonc #asco20 @md_arianemacedo @ludhmilahajjar
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @md_arianemacedo: Happy to see our paper about #dexrazoxane preventing #cardiotoxicity in Breast cancer being cited during #ACCcardioOnc…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @OncoCard_Ganken: Efficacy of Dexrazoxane in Preventing #Anthracycline Cardiotoxicity in #BreastCancer https://t.co/BuKgkaZ200 #Cardiot…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @OncoCard_Ganken: Efficacy of Dexrazoxane in Preventing #Anthracycline Cardiotoxicity in #BreastCancer https://t.co/BuKgkaZ200 #Cardiot…
RT @md_arianemacedo: Happy to see our paper about #dexrazoxane preventing #cardiotoxicity in Breast cancer being cited during #ACCcardioOnc…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @md_arianemacedo: Happy to see our paper about #dexrazoxane preventing #cardiotoxicity in Breast cancer being cited during #ACCcardioOnc…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @DocBanks84: Great meta-analysis on the reduction in CHF and cardiac events using DEX with ATs for BC; based on clinical trial data. Per…
RT @md_arianemacedo: Happy to see our paper about #dexrazoxane preventing #cardiotoxicity in Breast cancer being cited during #ACCcardioOnc…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
يمكن أن تنشأ ضعف القلب أيضا من العلاج الانثراسيكلين. تم تسليط الضوء على قدرة Dexrazoxane على مكافحة السمية خلال ورشة عمل #ACCCardioOnc. اقرأ هذه الورقة عن فعاليتها في نقاط # breastcancer في العدد الأول من #JACCCardioOnc. https://t.co/ZFv6Gl9Wsy https://
RT @DocBanks84: Great meta-analysis on the reduction in CHF and cardiac events using DEX with ATs for BC; based on clinical trial data. Per…
RT @DocBanks84: Great meta-analysis on the reduction in CHF and cardiac events using DEX with ATs for BC; based on clinical trial data. Per…
Great meta-analysis on the reduction in CHF and cardiac events using DEX with ATs for BC; based on clinical trial data. Perhaps a large RCT will change practice. I imagine this may benefit from an international effort. @onco_cardiology @PrevCardioOnc @AnaB
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @md_arianemacedo: Happy to see our paper about #dexrazoxane preventing #cardiotoxicity in Breast cancer being cited during #ACCcardioOnc…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @md_arianemacedo: Happy to see our paper about #dexrazoxane preventing #cardiotoxicity in Breast cancer being cited during #ACCcardioOnc…
RT @md_arianemacedo: Happy to see our paper about #dexrazoxane preventing #cardiotoxicity in Breast cancer being cited during #ACCcardioOnc…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
@Ritabt
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @md_arianemacedo: Happy to see our paper about #dexrazoxane preventing #cardiotoxicity in Breast cancer being cited during #ACCcardioOnc…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
Happy to see our paper about #dexrazoxane preventing #cardiotoxicity in Breast cancer being cited during #ACCcardioOnc pre-conference . Looking forward to attend all #cardioOnco sessions during #ACC2020 in Chicago this March !
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
RT @JACCJournals: Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted durin…
Cardiotoxcity can also arise from anthracycline treatment. Dexrazoxane's ability to combat toxicity was highlighted during #ACCCardioOnc pre-conference workshop. Read this paper on its efficacy in #breastcancer pts in the first issue of #JACCCardioOnc. htt
RT @JACCJournals: The next issue of #JACCCardioOnc is one week away! Can't wait? Reread the most downloaded articles from the first issue.…
RT @md_arianemacedo: Looking forward to reading the second issue of #JACCCardioOnc . Pleased to see that cardioprotection in breast cancer…
RT @md_arianemacedo: Looking forward to reading the second issue of #JACCCardioOnc . Pleased to see that cardioprotection in breast cancer…
RT @JACCJournals: The next issue of #JACCCardioOnc is one week away! Can't wait? Reread the most downloaded articles from the first issue.…
RT @md_arianemacedo: Looking forward to reading the second issue of #JACCCardioOnc . Pleased to see that cardioprotection in breast cancer…
RT @md_arianemacedo: Looking forward to reading the second issue of #JACCCardioOnc . Pleased to see that cardioprotection in breast cancer…
RT @JACCJournals: The next issue of #JACCCardioOnc is one week away! Can't wait? Reread the most downloaded articles from the first issue.…
RT @JACCJournals: The next issue of #JACCCardioOnc is one week away! Can't wait? Reread the most downloaded articles from the first issue.…
Looking forward to reading the second issue of #JACCCardioOnc . Pleased to see that cardioprotection in breast cancer has received so much attention marking our article among the most downloaded from the first issue! #BC #cardioprotection @rafabran
RT @JACCJournals: The next issue of #JACCCardioOnc is one week away! Can't wait? Reread the most downloaded articles from the first issue.…
The next issue of #JACCCardioOnc is one week away! Can't wait? Reread the most downloaded articles from the first issue. 4️⃣: @md_arianemacedo and colleagues discuss the efficacy of dexrazoxane in preventing #cardiotoxicity in #breastcancer patients. https
RT @JACCJournals: In a meta-analysis including a total of 2,177 breast cancer patients, dexrazoxane reduced the risk of #heartfailure and c…
RT @md_arianemacedo: So honoured to see my paper on the very first issue of #JACCCO. Hapiness is my word for today. Efficacy of Dexrazoxane…
RT @DrDiegoDelgado: Great systematic review and meta-analysis by @md_arianemacedo Efficacy of Dexrazoxane in Preventing Anthracycline Cardi…
RT @DrDiegoDelgado: Great systematic review and meta-analysis by @md_arianemacedo Efficacy of Dexrazoxane in Preventing Anthracycline Cardi…
RT @DrDiegoDelgado: Great systematic review and meta-analysis by @md_arianemacedo Efficacy of Dexrazoxane in Preventing Anthracycline Cardi…
Great systematic review and meta-analysis by @md_arianemacedo Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoy @macexicity in Breast Cancer https://t.co/ijFMKrJSen
Thanks @PortalOnconews for the partnership in promoting oncocardiology among oncologists! https://t.co/PmphmeZrUM
#JACCCardioOnc In a meta-analysis including a total of 2,177 #breast #cancer patients, dexrazoxane reduced the risk of #heartfailure and cardiac events without a significant impact in cancer outcomes. https://t.co/0E5y2238l2